Literature DB >> 10779545

5-lipoxygenase is phosphorylated by p38 kinase-dependent MAPKAP kinases.

O Werz1, J Klemm, B Samuelsson, O Rådmark.   

Abstract

5-lipoxygenase (5-LO) catalyzes the initial steps in the formation of leukotrienes, a group of inflammatory mediators derived from arachidonic acid (AA). Here we describe that activation of p38 mitogen-activated protein kinase in human polymorphonuclear leukocytes and in Mono Mac 6 cells leads to activation of downstream kinases, which can subsequently phosphorylate 5-LO in vitro. Different agents activated the 5-LO kinase activities, including stimuli for cellular leukotriene biosynthesis (A23187, thapsigargin, N-formyl-leucyl-phenylalanine), compounds that up-regulate the capacity for leukotriene biosynthesis (phorbol 12-myristate 13-acetate, tumor necrosis factor alpha, granulocyte/macrophage colony-stimulating factor), and well known p38 stimuli as sodium arsenite and sorbitol. For all stimuli, 5-LO kinase activation was counteracted by SB203580 (3 microM or less), an inhibitor of p38 kinase. At least two p38-dependent 5-LO kinase activities were found. Based on migration properties in in-gel kinase assays and immunoreactivity, one of these was identified as mitogen-activated protein kinase-activated protein kinase 2 (MAPKAP kinase 2). The other appeared to be MAPKAP kinase 3; however, it could not be excluded that also other p38-dependent kinases contributed. When polymorphonuclear leukocytes were incubated with sodium arsenite (strong activator of 5-LO kinases), platelet-activating factor and exogenous AA, there was a 4-fold increase in 5-LO activity as compared with incubations with only platelet-activating factor and AA. This indicates that 5-LO phosphorylation can be one factor determining cellular 5-LO activity.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10779545      PMCID: PMC25816          DOI: 10.1073/pnas.050588997

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  45 in total

1.  Activation of MAP kinase-activated protein kinase 2 in human neutrophils after phorbol ester or fMLP peptide stimulation.

Authors:  Y L Zu; Y Ai; A Gilchrist; M E Labadia; R I Sha'afi; C K Huang
Journal:  Blood       Date:  1996-06-15       Impact factor: 22.113

2.  Inhibition of mitogen-activated protein kinase kinase blocks activation and redistribution of 5-lipoxygenase in HL-60 cells.

Authors:  R A Lepley; F A Fitzpatrick
Journal:  Arch Biochem Biophys       Date:  1996-07-01       Impact factor: 4.013

3.  Tyrosine kinase activity modulates catalysis and translocation of cellular 5-lipoxygenase.

Authors:  R A Lepley; D T Muskardin; F A Fitzpatrick
Journal:  J Biol Chem       Date:  1996-03-15       Impact factor: 5.157

4.  3pK, a new mitogen-activated protein kinase-activated protein kinase located in the small cell lung cancer tumor suppressor gene region.

Authors:  G Sithanandam; F Latif; F M Duh; R Bernal; U Smola; H Li; I Kuzmin; V Wixler; L Geil; S Shrestha
Journal:  Mol Cell Biol       Date:  1996-03       Impact factor: 4.272

5.  Identification of mitogen-activated protein (MAP) kinase-activated protein kinase-3, a novel substrate of CSBP p38 MAP kinase.

Authors:  M M McLaughlin; S Kumar; P C McDonnell; S Van Horn; J C Lee; G P Livi; P R Young
Journal:  J Biol Chem       Date:  1996-04-05       Impact factor: 5.157

6.  Mitogen-activated protein kinases activate the serine/threonine kinases Mnk1 and Mnk2.

Authors:  A J Waskiewicz; A Flynn; C G Proud; J A Cooper
Journal:  EMBO J       Date:  1997-04-15       Impact factor: 11.598

Review 7.  Parallel signal processing among mammalian MAPKs.

Authors:  E Cano; L C Mahadevan
Journal:  Trends Biochem Sci       Date:  1995-03       Impact factor: 13.807

8.  Mutations at the C-terminal isoleucine and other potential iron ligands of 5-lipoxygenase.

Authors:  T Hammarberg; Y Y Zhang; B Lind; O Radmark; B Samuelsson
Journal:  Eur J Biochem       Date:  1995-06-01

Review 9.  Mitogen and stress response pathways: MAP kinase cascades and phosphatase regulation in mammals and yeast.

Authors:  A J Waskiewicz; J A Cooper
Journal:  Curr Opin Cell Biol       Date:  1995-12       Impact factor: 8.382

10.  Identification of anisomycin-activated kinases p45 and p55 in murine cells as MAPKAP kinase-2.

Authors:  E Cano; Y N Doza; R Ben-Levy; P Cohen; L C Mahadevan
Journal:  Oncogene       Date:  1996-02-15       Impact factor: 9.867

View more
  44 in total

Review 1.  The organization and consequences of eicosanoid signaling.

Authors:  Roy J Soberman; Peter Christmas
Journal:  J Clin Invest       Date:  2003-04       Impact factor: 14.808

Review 2.  ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions.

Authors:  Philippe P Roux; John Blenis
Journal:  Microbiol Mol Biol Rev       Date:  2004-06       Impact factor: 11.056

3.  Redundant and Cooperative Roles for Yersinia pestis Yop Effectors in the Inhibition of Human Neutrophil Exocytic Responses Revealed by Gain-of-Function Approach.

Authors:  Amanda R Pulsifer; Aruna Vashishta; Shane A Reeves; Jennifer K Wolfe; Samantha G Palace; Megan K Proulx; Jon Goguen; Sobha R Bodduluri; Bodduluri Haribabu; Silvia M Uriarte; Matthew B Lawrenz
Journal:  Infect Immun       Date:  2020-02-20       Impact factor: 3.441

4.  Phenotypically Silent Bone Morphogenetic Protein Receptor 2 Mutations Predispose Rats to Inflammation-Induced Pulmonary Arterial Hypertension by Enhancing the Risk for Neointimal Transformation.

Authors:  Wen Tian; Xinguo Jiang; Yon K Sung; Eric Shuffle; Ting-Hsuan Wu; Peter N Kao; Allen B Tu; Peter Dorfmüller; Aiqin Cao; Lingli Wang; Gongyong Peng; Yesl Kim; Patrick Zhang; James Chappell; Shravani Pasupneti; Petra Dahms; Peter Maguire; Hassan Chaib; Roham Zamanian; Marc Peters-Golden; Michael P Snyder; Norbert F Voelkel; Marc Humbert; Marlene Rabinovitch; Mark R Nicolls
Journal:  Circulation       Date:  2019-08-29       Impact factor: 29.690

5.  Proteomic identification of 14-3-3zeta as a mitogen-activated protein kinase-activated protein kinase 2 substrate: role in dimer formation and ligand binding.

Authors:  David W Powell; Madhavi J Rane; Brian A Joughin; Ralitsa Kalmukova; Jeong-Ho Hong; Bruce Tidor; William L Dean; William M Pierce; Jon B Klein; Michael B Yaffe; Kenneth R McLeish
Journal:  Mol Cell Biol       Date:  2003-08       Impact factor: 4.272

6.  5-Lipoxygenase: mechanisms of regulation.

Authors:  Olof Rådmark; Bengt Samuelsson
Journal:  J Lipid Res       Date:  2008-11-05       Impact factor: 5.922

7.  Phospholipid Ozonation Products Activate the 5-Lipoxygenase Pathway in Macrophages.

Authors:  Karin A Zemski Berry; Robert C Murphy
Journal:  Chem Res Toxicol       Date:  2016-08-03       Impact factor: 3.739

Review 8.  Leukotrienes in pulmonary arterial hypertension.

Authors:  Wen Tian; Xinguo Jiang; Yon K Sung; Jin Qian; Ke Yuan; Mark R Nicolls
Journal:  Immunol Res       Date:  2014-05       Impact factor: 2.829

9.  Molecular pharmacological profile of the nonredox-type 5-lipoxygenase inhibitor CJ-13,610.

Authors:  Lutz Fischer; Dieter Steinhilber; Oliver Werz
Journal:  Br J Pharmacol       Date:  2004-06-14       Impact factor: 8.739

10.  Therapeutic targets and limits of minocycline neuroprotection in experimental ischemic stroke.

Authors:  Noriyuki Matsukawa; Takao Yasuhara; Koichi Hara; Lin Xu; Mina Maki; Guolong Yu; Yuji Kaneko; Kosei Ojika; David C Hess; Cesar V Borlongan
Journal:  BMC Neurosci       Date:  2009-10-06       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.